This most up-to-date twist while in the Lykos Therapeutics saga threatens a major overhaul of the corporate’s technique and direction, with Musk ally and billionaire Trader Antonio Gracias showing up to choose to acquire the business again towards its nonprofit drug enhancement roots and a far more Doblinite philosophy.Probably the most hotly arg